Close Menu
    Wall Street

    Eli Lilly stock major crash upcoming – from $900 -> $450 this year

    Hello regards,

    This is a stock that hit 24B in revenue in 2011, end of 2022 their revenue was only 28B. How can a stock go up 2414% with only 4B gain in revenue?

    Eli Lilly's stock is expected to crash at least 50% in the rest half of the year. Why? Revenue is on a decline. It missed it's revenue last Q. Revenue peaked at 9B in September and ever since then it's been going down. Everyone keeps saying Mounjaro but if it's not reflecting in sales. What's the point?

    The stock's value has run up insane but the revenue and EPS growth doesn't match. Revenue goes down from 9M to 8.7M in the last 2 quarters and the stock's up like 40%.

    I urge all Eli Lilly investors to liquidate their stocks asap and buy puts. When it crashes back down to $450, you can re-enter in for a cheaper price.

    Eli Lilly stock major crash upcoming – from $900 -> $450 this year
    byu/AdventurousGood5214 inwallstreetbets



    Posted by AdventurousGood5214

    View 20 Comments

    20 Comments

    2. elbay on

      They make insulin, a drug you cannot live without and tirzepatide a drug *you* probably shouldn’t live without.

      People forget but you can’t just drop the ozempic after you lose the weight. It’s the perfect fucking drug.

      Also one more advantage, it is an american company so it can only ever go up.

    3. MinimumCat123 on

      Buying puts on a pharma company that makes insulin, diabetes meds, weight loss drugs, with an alzheimer’s treatment in the pipeline… during an obesity epidemic and a rapidly aging population… regarded

    7. Ashalots on

      This is the most valuable pharma company in the world, very unlikely to half its price without any good reason, sure it may drop a bit, but it’s similar to Costco stock to me

    9. failf0rward on

      The demand for this type of drug (GLP-1/semaglutide/etc) is going to be insane in 10 years. I don’t know where Lilly specifically will be in the race at that point, but once the supply ramps up and people understand the impact of the drugs, it’s really going to change a lot of things. I use the OZEM ETF so I don’t have to quite pick the winner.

    10. Putt____naked on

      Hahahahaha sorry buddy puts was the wrong play. This stock goes nowhere but up in the near future.

    11. Mandoriax on

      they make products people literally cannot live without and you expect them to loose half their market value just because according to numbers they are a bit overvalued?

      Sorry but unless their product turn out to have major health risks, they will at most loose 5-10%. Rather I expect the opposite since with our modern lifestyle the demand for their product will only increase.

    15. GrabAColdOne on

      Calls it is. The only thing currently limiting Mounjaro and Zephound sales is manufacturing capacity. Tirzepatide is better at A1C reduction and weight loss than Semaglutide (Ozempic/Wegovy). It will also probably get FDA approval for sleep apnea and maybe even CKD. They are projecting to have more manufacturing online soon and then the sky is the limit.

    16. MDRtransplant on

      Bad take

      Ozempic is literally the “miracle” drug.

      There are many pharma companies worth buying puts… Eli Lilly is not one of them.

    Leave A Reply
    Share via